6550--DNA Extraction Reagents

SOL #: 36C26326R0054Award NoticeSole Source

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NETWORK CONTRACT OFFICE 23 (36C263)
Saint Paul, MN, 55101, United States

Place of Performance

Minneapolis, MN

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 29, 2026
2
Last Updated
Jun 2, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs, Network Contracting Office 23, has awarded a Firm Fixed-Price contract to PROMEGA CORPORATION for DNA Extraction Reagents for the Minneapolis VA Health Care System. The award, under solicitation number 36C26326R0054, is valued at $124,143.07.

Scope of Work

This award procures Promega branded DNA Extraction Reagents specifically for the Minneapolis VA Health Care System (MVAHCS). These reagents are essential for DNA extraction and quantification using existing Promega Maxwell® RSC and 48 RSC DNA extractors and the Promega Quantus™ fluorometer. The reagents support various high-level molecular testing, including JAK2, Hereditary Hemochromatosis, Myeloid Panel, Solid Tumor Panel, and LUNG RT-48 testing. Key deliverables included specific Promega kits (e.g., Maxwell® RSC Blood DNA, Maxwell® RSC RNA FFPE Kit, Maxwell® RSC DNA FFPE Kit, QuantiFluor® ONE dsDNA System).

Contract Details

  • Awardee: PROMEGA CORPORATION
  • Award Value: $124,143.07
  • Award Date: June 1, 2026
  • Contract Type: Firm Fixed-Price
  • Solicitation Number: 36C26326R0054
  • Set-Aside: Full and Open Competition
  • Product Service Code: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
  • NAICS Code: 325413 (In-Vitro Diagnostic Substance Manufacturing)
  • Periods of Performance:
    • Base Period: June 1, 2026 - September 30, 2026
    • Option Period 1: October 1, 2026 - September 30, 2027
    • Option Period 2: October 1, 2027 - September 30, 2028
    • Option Period 3: October 1, 2028 - September 30, 2029
    • Option Period 4: October 1, 2029 - September 30, 2030
  • Place of Performance: Minneapolis VA Health Care System, One Veterans Drive, Minneapolis, MN 55417, USA.

Justification & Evaluation

The procurement was justified as a Brand Name Only requirement for Promega Corporation products. This was due to the proprietary nature of the reagents, which are exclusively compatible with the MVAHCS's existing Promega Maxwell RSC and Quantus TM fluorometer equipment, previously acquired under a sole-source contract. The original solicitation was evaluated using a Lowest Price Technically Acceptable (LPTA) process.

Contact Information

Robert Bennett, Contract Specialist, robert.bennett8@va.gov, 319-339-7079.

People

Points of Contact

Robert BennettContract SpecialistPRIMARY

Files

Files

Download
Download
Download
Download

Versions

Version 3Viewing
Award Notice
Posted: Jun 2, 2026
Version 2
Solicitation
Posted: Apr 30, 2026
View
Version 1
Pre-Solicitation
Posted: Apr 29, 2026
View
6550--DNA Extraction Reagents | GovScope